S4845-118

Introduced

To lower the cost of drugs for all Americans.

118th Congress Introduced Jul 30, 2024

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To lower the cost of drugs for all Americans., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Finance, Government Operations.

Who Benefits and How

health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section S1: 1. Short title This Act may be cited as the Prescription Drug Affordability and Access Act.
  • Section idB32D2B84899A46899A50AE2AAD36391D: 2. Establishment of the Bureau of Prescription Drug Affordability and Access There is established within the Department of Health and Human Services a bureau,...
  • Section id3E156686D7A34D5A802338454E6A3C28: 3. Prescription drug consumer price protections The Bureau shall conduct annual reviews of the prices of prescription drugs to ensure that the wholesale...
  • Section idd970a953083a4776bc565c597c581124: 4. Definitions In this Act: The term conflict of interest means an association, including a financial or personal association, or past employment, that has the...
  • Section id79e4f08a9e3c4761a6978942c92bdff0: 5. Repeal of Medicare's noninterference clause Section 1860D–11 of the Social Security Act (42 U.S.C. 1395w–111) is amended by striking subsection (i).

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, To lower the cost of drugs for all Americans., changes federal law or congressional policy affecting health care providers and patients.

Key Policy Areas

Healthcare, Finance, Government Operations

Primary Purpose

This bill, To lower the cost of drugs for all Americans., changes federal law or congressional policy affecting health care providers and patients.

Policy Domains

Healthcare Finance Government Operations

Whole bill

Identified Gains
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: is
health care providers and patients: ,
Identified Costs
  • federal implementing agencies
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: is
federal implementing agencies: ,
health care providers and patients: ,

Legislative Progress

Introduced
Introduced Committee Passed
Jul 30, 2024

Mr. Booker (for himself and Mr. Sanders) introduced the following …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Finance Government Operations
Actor Mappings
"secretary_of_health_and_human_services"
→ Secretary of Health and Human Services

Key Definitions

Terms defined in this bill

1 term
"manufacturer, with respect to a prescription drug," §idd970a953083a4776bc565c597c581124

an entity that— is the holder of the approved application under section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) or under section 351 of the Public Health Service Act (42 U.S.C. 262)

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology